FDA Approves New Drug for Pneumonia

FDA has approved Xacduro injection (Durlobactam, a new molecular entity in combination with sulbactam) for treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia caused by bacteria called Acinetobacter baumannii-calcoaceticus complex 

FDA Approves Durbolactam (News Release).